Arcus Biosciences, Inc.

From Arcus Biosciences's results release of 4 ноября 2026 г.; its quarterly report has since been filed.

• Revenue

  Actual

  9M $

  -65 % y/y ↓
  -78 % q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  -1,00 $

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -131M $

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.